Parasitology Research

, Volume 88, Issue 5, pp 395–397

Chemotherapeutic approaches to schistosomes: current knowledge and outlook

Authors

  •  A. Harder
    • Biological Chemical Evaluation, Animal Health Business Group Bayer AG Monheim, 51368 Leverkusen, Germany
Original Paper

DOI: 10.1007/s00436-001-0588-x

Cite this article as:
Harder, A. Parasitol Res (2002) 88: 395. doi:10.1007/s00436-001-0588-x

Abstract.

The chemotherapy of schistosomiasis has improved greatly in the last few decades. There are three drugs available: metrifonate (active against Schistosoma haematobium), oxamniquine (active against Schistosoma mansoni) as narrow spectrum drugs and praziquantel, which is effective against all important adult schistosome species and their immature stages, as the drug of choice.

Download to read the full article text

Copyright information

© Springer-Verlag 2002